维普中文期刊产品整合服务
41篇 您的检索式:作者名="Giordan"
    题名 作者 年代 出处 被引量
1Home-made fenestrated amplatzer occluder for atrial septal defect and pulmonary arterial hypertension显示文摘我们报导一个病人的管理与根据氏族的缺点( ASD )和有最近的严重肺的 hypertension.A 65岁的孩子男性诊断了的 atrial atrial serital 缺点被指我们有休息和锻练的患心脏代偿失调的正确的心失败的中心导致了 dispnea ,严重肺的 hypertension.Right 心 catheterization 证实了一个吝啬的肺的压力关于 55 mmHg 和有一个顺从的大汽球的 2.7 .An 吸藏测试的 Qp/QsFabio Dell'Avvocata Gianluca Rigatelli Paolo Cardaioli Massimo Giordan 2011Journal of Geriatric Cardiology2011,8,2:3
2Prolonged high-pressure balloon angioplasty of femoropopliteal lesions:Impact on stent implantation rate and mid-term outcome显示文摘ObjectivesTo 在 stent 培植率和回顾地注册的 femoropopliteal lesions.MethodsWe 的延长高压力 angioplasty 的中间的结果上估计影响从 2011 年 1 月的 620 个连续病人到 2011 年 12 月(75.6 ±12.3 年, 355 男性, 76.5% 在卢班 5-6 ) ,为批评手足局部缺血参考了并且提交了到 femoropopliteal 损害的延长高压的 angioplasty。延长高压的 angioplasty 的定义为至少 120 s 包括膨胀到至少 18 atm。程序的数据,和临床、仪器的后续被分析估计比较喜欢的培植率和中间的 outcomes.ResultsThe 接近的 stent 是 ipsilateral 在 433/620 病人(69.7%) 和在 164/620 (26.4%) 的 contralateral 转线路的大腿骨的 antegrade 并且腿弯部后退 +在 23/620 (3.7%)的大腿骨的 antegrade 。技术在 193/620 病人(31.2%) 在 427/620 病人(68.8%) 和 endoluminal angioplasty 包括了 subintimal angioplasty。延长高压力汽球 angioplasty 过程在 86.2% 是成功的(次要的 intra 程序的复杂并发症率 15.7 %) , stent 培植在 74 个病人(11.9%) 被执行,与脚关节臂的索引的重要改进(0.29 ±0.6 对 0.88 ±0.3, P <00.1 ) 并且卢班(5.3 ±0.8 对 0.7 ±1.9, P <0.01 ) , 86.7% 的主要明显率, Doppler 超声和在 18.1 ± 的吝啬的后续的 14.8% 的目标损害 revascularization 上的 18.6 % 的狭窄;6.4 个月(范围 1-24 月) 。第二等的明显率高是 87.7%.ConclusionsProlonged femoropopliteal 损害的压力 angioplasty 看起来安全、有效允许可接受的明显和狭窄在期中考试上评价。Gianluca Rigatelli Mariano Palena Paolo Cardaioli Fabio dell'Avvocata Massimo Giordan Dobrin Vassilev Marco Manzi 2014Journal of Geriatric Cardiology2014,11,2:2
3Iliac artery thrombosis after aortic ballon counterpulsation: treatment with intraarterial tirofiban, manual thrombectomy and stenting显示文摘Rigatelli G Giordan M Candaioli P 2006Int J Cardiol2006,112,3:1
4Prophylactic endovascular management of peripheral artery disease in elderly candidates prior to cardiac surgery显示文摘Background and objectives Peripheral vascular disease (PVD) is a major risk factor in candidates for cardiac surgery and can impact morbidity and mortality in the perioperative and follow-up period. Elderly patients with PVD may benefit from endovascular treatment prior to cardiac surgery. We sought to assess the common clinical settings requiring prophylactic endovascular treatment before coronary surgery in elderly patients, the results, and the mid-term impact on subsequent revascularization. Methods Between November 2002 and June 2006, 37 patients (25 males, mean age 79.9±8.3 years, mean serum creatinine 1.9±0.6 mg/dl) underwent endovascular repair of PVD before cardiac surgery. For each patient, diagnostic methods, indications for intervention, types of interventions, procedural success, and complications were recorded. Results Four clinical settings were identified: renal artery stenting prior to coronary surgery (7 patients), iliac artery angioplasty and stenting (10 patients) in order to facilitate aortic balloon pump insertion after surgery, subclavian artery angioplasty and stenting prior to utilization of ipsilateral arterial conduits bypass surgery (5patients), and carotid artery stenting before coronary surgery (15 patients). Technical success was achieved in all patients (100%);complications included brachial artery occlusion (1 patient), minor stroke (2 patients), contrast nephropathy (1 patient), and minor bleeding at the puncture site (3 patients). All patients underwent successful coronary or valvular surgery; no patients died in the perioperative period. After a mean follow-up of 26.6±3.1 months, all patients are alive and free from anginal symptoms or valvular dysfunction without clinical or Doppler ultrasonography evidence of restenosis of the implanted peripheral vascular stents. Conclusions It is not unusual for elderly patients who are candidates for cardiac surgery to require endovascular intervention for significant PVD prior to coronary bypass or valvular surgery. The results showed a low complication rate. The cardiologists have a fundamental role,not only in the diagnosis of peripheral vascular stenosis, which was seen frequently in patients with significant CAD, but also in the appropriate endovascular management of these high-risk patients.Gianluca Rigatelli Paolo Cardaioli Massimo Giordan Loris Roncon Emiliano Bedendo Tranquillo Milan Giorgio Rigatelli 2006Journal of Geriatric Cardiology2006,3,2:1
5Effective prevention of massive periprocedural embolism during renal artery stenting 显示文摘Cardaioli P Rigatelli G Giordan M 2006Cardiovasc Revasc Med2006,7,4:1
6T-cell cloning in human type 1 diabetes显示文摘Carla Giordan 1999Diabetes Metabolism Reviews1999,8,11:1
7Congenital coronary artery-left ventricle direct micro-fistulas may cause effort angina and positive stress tests in Western adults显示文摘Gianluca Rigatelli Fabio Dell'Avvocata Massimo Giordan Paolo Cardaioli 2016Journal of Geriatric Cardiology2016,13,1:1
8Effective prevention of massive periprocedural embolism during renal artery stenting显示文摘 Rigatelli G Giordan M 2006Cardiovasc Rerase Med2006,7,:1
9Evaluation of a new hyaluronic acid dermal filler for volume restoration 显示文摘Alessandrini A Fino P Giordan N 2015J Cosmet Laser Ther2015,20,:1
10Impact of Interatrial Septum Anatomic Features on Short‐ and Long‐ T erm Outcomes After Transcatheter Closure of Patent Foramen Ovale: Single Device Type Versus Anatomic‐ D riven Device Selection Strategy显示文摘GIANLUCA RIGATELLI FABIO DELL’AVVOCATA RAMESH DAGGUBATI HO THUONG DUNG NGUYEN THUONG NGHIA ARAVINDA NANJIUNDAPPA MASSIMO GIORDAN PAOLO CARDAIOLI 2013J Int Cardiol2013,,4:1
11Effective prevention of massive periproceduralem bolism during renal artery stenting 显示文摘Cardaioli P Rigatelli G Giordan M 2006Cardiovasc Revasc Med2006,7,4:1
12Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemia显示文摘Hasegawa D Bugarin C Giordan M 2013Blood Cancer J2013,3,11:1
13Uhrastural detection of DNA-incorporated bromodeoxyuridine in resin embedded brain tissue 显示文摘Migheli A Mocellin C Giordane MT 1991Histochem1991,95,6:1
14Endovascular management of patients with coronary artery disease and diabetic foot syndrome: A long-term follow-up显示文摘背景将调查糖尿病的脚病人的全球冠、外部的 interventional 治疗的长期的结果。我们回顾地包括了 220 个糖尿病的病人的方法(78.5 +/- 15.8 年, 107 女性,都与 Fontaine III 或 IV 班) 被指我们糖尿病的脚症候群的中心和到 2010 年 12 月的从 2006 年 1 月的严重手足局部缺血。病人们被 interventional 心脏病专家和 diabetologists 的一个队评估以便估计伴随物的存在冠的动脉疾病(CAD ) 和对冠的 revascularization 的最终的需要。压力回响在诊断外部 angiography 前在所有病人被执行。有为冠的 angiography 的指示的病人被提交到联合诊断 angiography 然后到最终的上演外设和冠的干预。Doppler ultrasonography 和在过程前后的 transcutaneous 氧压力(TcPO2 ) 的脚 transcutaneous oximetry 象 stress-echocardiography 一样被执行并且在 1 和 6 个月并且每年联合了 cardiologic 和糖尿病的检查。结果 Stress-echocardiography 在 94/220 病人被执行并且结果在经历了的 56 个病人积极联合了冠、外部的 angiography。在 126 个病人的其余部分,联合了冠、外部的 angiography 在 35 个病人为冠的心疾病的伴随物症状直接被执行。冠的 revascularization 被判定在 85/129 病人必要并且在 13 个病人在 72 个病人并且通过手术在外部干预以后经皮地被执行。为糖尿病的脚干预,比较喜欢的途径是 ipsilateral 在 170/220 病人(77.7%) 和在 40/220 病人(18.8%) 的 contralateral 转线路的大腿骨的 antegrade 并且腿弯部后退 + 在 10/220 病人(4.5%) 的大腿骨的 antegrade。汽球 angioplasty 在 252 条腿被执行(32 个病人有的双边的疾病) :过程与溃疡在 233/252 腿(92.4%) 愈合在 TcPO2 和 ABI 在有 94.8% 的立即的成功率和重要改进的 239/252 腿是成功的。从主要切断的自由在 3.1 汣湩捩污 ? 的吝啬的后续是 82.8%?Gianluca Rigatelli Paolo Cardaioli Fabio dell'Avvocata Massimo Giordan Giovanna Lisato Francesco Mollo 2011Journal of Geriatric Cardiology2011,8,2:1
15An uncommon coronary artery fistula显示文摘Massimo Giordan Gianluca Rigatelli Massimo Rinuncini Loris Roncon Gabriele Braggion Stefano Panin Emiliano Bedendo Pietro Zonzin 2005Cardiovascular Revascularization Medicine2005,,3:1
16That goal thing显示文摘Giordan J 1995Research Technology Management1995,,38:1
17Iliac artery thrombosis after aortic balloon counterpulsation: treatment with intraarterial tirofiban, manual thrombectomy and stenting 显示文摘Rigatelli G Giordan M Cardaioli P 2006IntJ Cardiol2006,112,3:1
18T-cell cloning in human type 1 diabetes显示文摘CARLA GIORDAN 1999Diabetes Metabolism Reviews1999,8,4:1
19Analysis of heat transfer in autoclave technology 显示文摘Antonucci V Giordan M Imparato S I 2001Polymer Composites2001,22,5:1
20It' s Time to Think Differently about R&D Assets and the CTO' s Role显示文摘Judith C Giordan Nir Kossovsky 0,,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费